108Labs announces smart bioreactor milk production platform
Image courtesy of 108Labs
Conjuring the Magic of Milk, cellular based milk production company 108Labs has announced its M2 smart bioreactor milk production platform. M2 is a turnkey wetware, software, and hardware milk-making stack driven by artificial intelligence to reduce the cost and accelerate the scaling of cell-cultured milk production worldwide.
The mission of 108Labs’ newly organised entities is to accelerate the future of human milk and replacement dairy across many health and food product fields with the M2 platform.
108Labs entities:
Pure Mammary Factors Inc was founded in December 2021 and is democratizing cell-cultured milks by making product research and commercialisation more affordable and accessible. A Pure dairy product is any cell-cultured milk product created with Pure Mammary Factors. Unlike raw milk, Pure mammary cell medium and growth factors produce Pure milks that are safe for human consumption right out of the cell without needing pasteurisation.
M2Health, Inc May was founded in May 2020 and is developing Pure therapeutic human milk for prescription drugs and humanized infant formula products.
M2Foods Inc was founded in September 2021 and is developing Pure foods including bovine artisanal cheeses and other replacement dairy food products.
108Labs and 108Labs entities are licensing M2 and collaborating with dairy, food and pharmaceutical partners to accelerate Pure food and health products to market worldwide.
“What 108Labs has accomplished as a self-funded, family-run incubator over the last decade is astonishing, but the future is even more amazing and I couldn’t be more excited to work with Shayne and 108Labs on the future of food,” comments Scott Matthews, COO, M2Foods.